Our data highlight the significance of early developmental disruptions in shaping neural circuits and molecular profiles implicated in schizophrenia, and suggest that ANO1 may represent a potential molecular target for understanding disease mechanisms and developing innovative therapeutic strategies. Here, ANO1 is linked to schizophrenia.